EULAV Asset Management’s Amgen AMGN Stock Holding History

EULAV Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,000	Closed	-$2.08M	–	294
2015 Q3	$2.08M	Sell	15,000 -4,000	-21%	-$631K	0.12%	219
2015 Q2	$2.92M	Hold	19,000	–	–	0.15%	198
2015 Q1	$3.04M	Hold	19,000	–	–	0.16%	198
2014 Q4	$3.03M	Sell	19,000 -2,000	-10%	-$312K	0.16%	194
2014 Q3	$2.95M	Buy	21,000 +3,300	+19%	+$431K	0.16%	198
2014 Q2	$2.1M	Sell	17,700 -18,000	-50%	-$2.08M	0.11%	248
2014 Q1	$4.4M	Hold	35,700	–	–	0.24%	151
2013 Q4	$4.08M	Hold	35,700	–	–	0.22%	158
2013 Q3	$4M	Sell	35,700 -300	-0.8%	-$32.5K	0.23%	154
2013 Q2	$3.55M	Buy	+36,000	New	+$3.74M	0.22%	162

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EULAV Asset Management's AMGN Position: Q4 2015 in Review

EULAV Asset Management sold out of Amgen (AMGN) in Q4 2015, closing a stake of 15,000 shares — an estimated $2.08M sold.

EULAV Asset Management first reported a position in AMGN in Q2 2013 and held it in 10 quarters. The position peaked at $4.4M in Q1 2014. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

EULAV Asset Management reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
EULAV Asset Management sold 15,000 Amgen shares in Q4 2015, an estimated $2.08M.
EULAV Asset Management first reported a position in Amgen in Q2 2013 and held it in 10 quarters.
EULAV Asset Management's Amgen position peaked at $4.4M in Q1 2014.
1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on EULAV Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.